Molecular mechanisms underlying thalassemia intermedia in Iran

Genetic Testing

Volumn 12, Issue 4, 2008, Pages 549-556

  Neishabury, Maryam ^a   Azarkeivan, Azita ^b   Oberkanins, Christian ^c   Esteghamat, Fatemehsadat ^a   Amirizadeh, Naser ^b   Najmabadi, Hossein ^a,d  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c VIENNALAB DIAGNOSTICS GMBH   (Austria)

^d Kariminejad Najmabadi Pathology and Genetics Center   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; DNA; HYDROXYUREA;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; DISEASE SEVERITY; FEMALE; GENE MUTATION; HEMATOLOGICAL PARAMETERS; HEMOGLOBINOPATHY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; THALASSEMIA; THALASSEMIA INTERMEDIA;

ADOLESCENT; ADULT; ALLELES; ALPHA-GLOBINS; ALPHA-THALASSEMIA; BASE SEQUENCE; BETA-GLOBINS; BETA-THALASSEMIA; CHILD; DELTA-GLOBINS; DELTA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENOTYPE; HEMOGLOBIN SUBUNITS; HUMANS; IRAN; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; THALASSEMIA; YOUNG ADULT;

EID: 57749096271     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2008.0018     Document Type: Article

References (29)

1. Amselem S, Nunes V, Vidaud M, et al. (1988) Determination of the spectrum of beta-thalassemia genes in Spain by use of dotblot analysis of amplified beta-globin DNA. Am J Hum Genet 43:95-100.
2. Badens C, Mattei MG, Imbert AM, et al. (2002) A novel mechanism for thalassaemia intermedia. Lancet 359:132-133.
3. Beris P, Deutsch S, Darbellay R (2004) Molecular pathology of thalassemia intermedia. Hematol J 5 Suppl 3:S199-S204.
4. Beris P, Solenthaler M, Deutsch S, et al. (1999) Severe inclusion body beta-thalassaemia with haemolysis in a patient double heterozygous for beta(0)-thalassaemia and quadruplicated alpha-globin gene arrangement of the anti-4.2 type. Br J Haematol 105:1074-1080.
5. Borgna-Pignatti C (2007) Modern treatment of thalassaemia intermedia. Br J Haematol 138:291-304.
6. Chehab FF, Der Kaloustian V, Khouri FP, et al. (1987) The molecular basis of beta-thalassemia in Lebanon: application to prenatal diagnosis. Blood 69:1141-1145.
7. de Andrade TG, Fattori A, Saad ST, et al. (2002) Molecular identification of Sicilian (deltabeta) degrees-thalassemia associated with beta-thalassemia and hemoglobin S in Brazil. Braz J Med Biol Res 35:873-876.
8. Faa V, Meloni A, Moi L, et al. (2006) Thalassaemia-like carriers not linked to the beta-globin gene cluster. Br J Haematol 132:640-650.
9. Grosveld F (1999) Activation by locus control regions? Curr Opin Genet Dev 9:152-157.
10. Hadavi V, Taromchi AH, Malekpour M, et al. (2007) Elucidating the spectrum of alpha-thalassemia mutations in Iran. Haematologica 92:992-993.
11. Haghshenass M, Ismail-Beigi F, Clegg JB, et al. (1977) Mild sickle-cell anaemia in Iran associated with high levels of fetal haemoglobin. J Med Genet 14:168-171.
12. Ho PJ, Hall GW, Watt S, et al. (1998) Unusually severe heterozygous beta-thalassemia: evidence for an interacting gene affecting globin translation. Blood 92:3428-3435.
13. Karimi M, Yarmohammadi H, Farjadian S, et al. (2002) Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G - > A) is the prevalent thalassemia intermedia allele. Hemoglobin 26:147-154.
14. Kulozik AE, Wainscoat JS, Serjeant GR, et al. (1986) Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet 39:239-244.
15. Kutlar A (2007) Sickle cell disease: a multigenic perspective of a single gene disorder. Hemoglobin 31:209-224.
16. Murru S, Loudianos G, Porcu S, et al. (1992) A beta-thalassaemia phenotype not linked to the beta-globin cluster in an Italian family. Br J Haematol 81:283-287.
17. Najmabadi H, Ghamari A, Sahebjam F, et al. (2006) Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet 9:93-97.
18. Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. (2001) The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 25:285-296.
19. Najmabadi H, Pourfathollah AA, Neishabury M, et al. (2002) Rare and unexpected mutations among Iranian beta-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica 87:1113-1114.
20. Oron-Karni V, Filon D, Oppenheim A, et al. (1998) Rapid detection of the common Mediterranean alpha-globin deletions/rearrangements using PCR. Am J Hematol 58:306-310.
21. Rahimi Z, Merat A, Gerard N, et al. (2006) Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum Biol 78:719-731.
22. Rund D, Cohen T, Filon D, et al. (1991) Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci USA 88:310-314.
23. Sutton M, Bouhassira EE, Nagel RL (1989) Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol 32:66-69.
24. Taher A, Isma'eel H, Cappellini MD (2006) Thalassemia intermedia: revisited. Blood Cells Mol Dis 37:12-20.
25. Tamagnini GP, Lopes MC, Castanheira ME, et al. (1983) Beta + thalassemia - Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia. Br J Haematol 54:189-200.
26. Thein SL (2005) Pathophysiology of {beta} Thalassemia - a guide to molecular therapies. Hematology Am Soc Hematol Educ Program 2005:31-37.
27. Travis S (2001) Diagnosis of sickle cell anemia and other hemoglobinopathies. Sickle cell newsletter. No. 2 (www.state.nj.us/health/fhs/ nbs/documents/hemo_prof.pdf)
28. Verma IC, Kleanthous M, Saxena R, et al. (2007) Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 31:439-452.
29. Wainscoat JS, Kanavakis E, Wood WG, et al. (1983) Thalassaemia intermedia in Cyprus: the interaction of alpha and beta thalassaemia. Br J Haematol 53:411-416.